Načítá se...
The impact of immuno-aging on SARS-CoV-2 vaccine development
The SARS-CoV-2 pandemic has almost 56 million confirmed cases resulting in over 1.3 million deaths as of November 2020. This infection has proved more deadly to older adults (those >65 years of age) and those with immunocompromising conditions. The worldwide population aged 65 years and older is...
Uloženo v:
| Vydáno v: | GeroScience |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer International Publishing
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7875765/ https://ncbi.nlm.nih.gov/pubmed/33569701 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11357-021-00323-3 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|